Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05891977
Other study ID # PID2020-114022RB-I00
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date October 26, 2023
Est. completion date June 30, 2024

Study information

Verified date November 2023
Source University of Barcelona
Contact Rosa M Lamuela Raventós, PhD
Phone +34-934020909
Email lamuela@ub.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Tomatoes and tomato-based products could play an important role in modulating microbiota-gut-brain axis (MGBA) interactions due to their high content of fiber and phytochemicals. Phytochemical metabolites derived from the consumption of tomato-based products can act directly as neurotransmitters in the central nervous system, crossing the blood-brain barrier, or indirectly by modulating the MGBA. These metabolites can thus alter gut bacterial composition and brain biochemistry. Therefore, researchers propose a new interventional study to assess the impact of daily tomato consumption in the organism, and to evaluate the effect on the MGBA. The final aim of this study is to spread a message of the health benefits of tomato consumption for the general population.


Description:

To evaluate the possible changes in microbiota and cognitive skills after consumption of tomato paste in a crossover randomized controlled study. Fifty healthy adults subjects (aged 40-55 years and consisting of 50% males and 50% females to assess possible sex-based responses) will be included. Participants will sign the informed consent and carry out a washout period without consuming any tomatoes or tomato-based products during 1 week. Participants will consume a daily amount of 0.5 g of tomato paste / kg of body weight following the regular diet plus consumption of low to moderate tomato or tomato-based products and other sources of lycopene (experimental intervention), and the normal diet plus consumption of low to moderate tomato or tomato-based products and other sources of lycopene (control intervention) during 3 months. Biological samples (plasma, peripheral blood mononuclear cells, serum, 24-hours urine, feces, and saliva) will be obtained at baseline and the end of each arm of the trial.


Recruitment information / eligibility

Status Recruiting
Enrollment 50
Est. completion date June 30, 2024
Est. primary completion date June 30, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 40 Years to 55 Years
Eligibility Inclusion Criteria: - Healthy adult subjects with BMI < 30 kg/m2 - Signed informed consent Exclusion Criteria: - Participants with tomato allergy or intolerance - Cardiovascular disease (cancer or diabetes) - Mental disorders (e.g. depression, dementia, autism, etc.) - Cardiovascular alterations in triglycerides or glucose - Participants with body mass index (BMI) > 30 kg/m2 - Current smokers - Frequent use of corticoids, nonsteroidal anti-inflammatory drugs - Volunteers with extreme eating habits (i.e. Atkins diet, very high protein diets, etc.) - Excessive alcohol consumption (>30 g/d for males and >20 g/d for females), - Pregnant or lactating women

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Intervention A - Tomato paste
Participants will consume a daily amount of 0.5 g of tomato paste / kg of body weight following the regular diet plus consumption of low to moderate tomato or tomato-based products and lycopene containing foods
Intervention B - Control
Participants will consume the regular diet plus consumption of low to moderate tomato or tomato-based products and lycopene containing foods

Locations

Country Name City State
Spain Department of Nutrition, Food Sciences and Gastronomy. School of Farmacy and Food Sciences. University of Barcelona. Barcelona

Sponsors (1)

Lead Sponsor Collaborator
University of Barcelona

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Changes in brain-derived neurotrophic factor (BDNF) after each intervention with tomato paste and the control intervention. Serum samples will be analysed for mature BDNF using a Mature BDNF Rapid ELISA kit. Baseline and after completed each intervention (3 months)
Primary Changes in cognitive function (executive) after each intervention with tomato paste and the control intervention. The Wisconsin Sorting Cards Test (WSCT) will assess strategic planning, organized searching, utilizing environmental feedback to shift cognitive sets, directing behaviour towards achieving a goal and modulating impulsive responding. Baseline and after completed each intervention (3 months)
Primary Changes in cognitive function (attention) after each intervention with tomato paste and the control intervention. The d2 Test will meausure selective and sustained attention and visual scanning speed. Processing speed, rule compliance, and quality of performance will be assess in participants. Baseline and after completed each intervention (3 months)
Primary Changes in cognitive function (memory) after each intervention with tomato paste and the control intervention. The face-name associative memory exam (FNAME) will assess associative memory function.Participants will be asked to remember a set of faces and the names they are paired with. After a 5-25 minute delay, participants will recall which of the faces and names they saw earlier. Baseline and after completed each intervention (3 months)
Primary Changes in cerebrovascular function after each intervention with tomato paste and the control intervention. Cerebrovascular function will be measured using functional magnetic resonance imaging (FMRI), a non-invasive method for assessing brain activity. FMRI maps blood oxygenation levels in the brain and estimates changes in the blood flow that depends on metabolic function and is correlated with specific brain region activities Baseline and after completed each intervention (3 months)
Primary Changes in the gut microbiota after each intervention with tomato paste and the control intervention. Fecal samples will be collected by the volunteers using a system for easy self-collection and stabilization of microbial DNA for gut microbiome profiling (OMNIgene - GUT). The genomic DNA will be extracted from fecal samples using the DNeasy PowerSoil Kit. Then, microbial profiling using 16S ribosomal RNA (rRNA) sequencing will be used to study microbial communities, specially bacterial phylogeny and taxonomy. Baseline and after completed each intervention (3 months)
Primary Changes in the polyphenols and carotenoids and their metabolites after each intervention with tomato paste and the control intervention. Carotenoids and polyphenols, and their metabolites derived from intestinal gut microbiota will be identified and quantified in human plasma, urine, feces, and saliva samples using High Performance Liquid Chromatography HPLC-LTQ-Orbitrap-MS/MS and HPLC-MS/MS techniques. Baseline and after completed each intervention (3 months)
Primary Changes in the short-chain fatty acids in plasma and feces samples after each intervention with tomato paste and the control intervention. After acidifying the fecal samples with formic acid, a quantification of short-chain fatty acids will be performed using gas chromatography by direct injection according to previously described methodology (Zhao et al., 2006). Baseline and after completed each intervention (3 months)
Primary Changes in bile acids in plasma and feces samples after each intervention with tomato paste and the control intervention. Bile acids will be assayed using a validated liquid chromatography-mass spectrometry (LC-MS) method Baseline and after completed each intervention (3 months)
Secondary Changes in Body mass index after each intervention with tomato paste and the control intervention. Body mass index (kg/m^2) will be calculated after measuring weight (kg) and height (meters). Baseline and after completed each intervention (3 months)
Secondary Changes in waist-to-hip ratio with tomato paste and the control intervention. Waist and hip circumferences (cm) will be measured in triplicate and then combined to report waist-to-hip ratio. Baseline and after completed each intervention (3 months)
Secondary Changes in anthropometric measurements after each intervention with tomato paste and the control intervention. Body mass index (kg/m^2) will be calculated after measure weight (kg) and height (meters). To evaluate waist-to-hip ratio, waist and hip circumferences (cm) will be measured in triplicate. Baseline and after completed each intervention (3 months)
Secondary Changes in body composition after each intervention with tomato paste and the control intervention. Body fat percentage will be measured using a bioelectrical impedance analysis monitor. Baseline and after completed each intervention (3 months)
Secondary Changes in blood pressure after each intervention with tomato paste and the control intervention. Diastolic and systolic blood pressure will be measured by a blood pressure monitor in triplicate. Baseline and after completed each intervention (3 months)
Secondary Changes in heart rate after each intervention with tomato paste and the control intervention. Heart rate (bpm) will be measured with an automatic monitor in triplicate. Baseline and after completed each intervention (3 months)
Secondary Changes in lipidic profile after each intervention with tomato paste and the control intervention. Total cholesterol, HDL-cholesterol, LDL-cholesterol and triglycerides (mg/dL) will be measured by molecular absorption spectrometry. Baseline and after completed each intervention (3 months)
Secondary Changes in liver function after each intervention with tomato paste and the control intervention. Alanine transaminase (ALT), aspartate transaminase (AST), alkaline phosphatase (ALP) and albumin will be assayed by immunoenzymatic methods. Baseline and after completed each intervention (3 months)
Secondary Changes in glucose after each intervention with tomato paste and the control intervention. Glucose (mg/dL) will be measured by molecular absorption spectrometry. Baseline and after completed each intervention (3 months)
Secondary Changes in pro- and anti-inflammatory biomarkers after each intervention with tomato paste and the control intervention. Cytokines (pg/mL), tumor necrosis factor a (TNF-a) (pg/mL) and C-reactive protein (CRP) (mg/dL) will be assayed by immunoenzymatic methods. Baseline and after completed each intervention (3 months)
Secondary Changes in nutrients and energy intake after each intervention with tomato paste and the control intervention. A 7-day food recall will be used. The data will be analyzed using a software called Programa de Càlcul Nutricional Professional (PCN Pro). Baseline and after completed each intervention (3 months)
Secondary Changes in quality of the diet after each intervention with tomato paste and the control intervention. Participants will fill the validated questionnaire measuring adherence to the Mediterranean diet. Baseline
Secondary Changes in physical activity after each intervention with tomato paste and the control intervention. Physical activity will be assessed with the ActiGraph® wGT3X-BT accelerometer. Baseline and after completed each intervention (3 months)
Secondary Changes in sleep quality after each intervention with tomato paste and the control intervention. Sleep quality will be assessed with the ActiGraph® wGT3X-BT accelerometer. Baseline and after completed each intervention (3 months)
Secondary Changes in quality of life after each intervention with tomato paste and the control intervention. Quality of life will be assessed with the WHOQOL-BREF. Baseline and after completed each intervention (3 months)
Secondary Sensory threshold and organoleptic analysis The recognition threshold of the five basic tastes will be determined through a classical sensory analysis test, employing a battery of solutions containing the molecules of interest. This test will include an organoleptic analysis of tomato paste to evaluate its aroma, taste (including acidity, sweetness, saltiness, umami), and hedonic sensation. Baseline
See also
  Status Clinical Trial Phase
Recruiting NCT05563805 - Exploring Virtual Reality Adventure Training Exergaming N/A
Completed NCT03708692 - Menstrual Cycle Phases on Recovery and Cognitive Function
Active, not recruiting NCT04505345 - Virtual Reality Cognitive Training in Alcohol Use Disorder N/A
Completed NCT04430465 - Effects of Wholegrains on Children's Health (KORN) N/A
Completed NCT02915913 - Effects of Exercise Training on Cognitive Function and Neurotrophic Factors in Overweight Adults N/A
Completed NCT01410097 - Physical and Cognitive Function - Look AHEAD Ancillary Study N/A
Completed NCT03826121 - Efficacy and Safety of Sesame Oil Cake Extract on Improvement of Cognitive Function N/A
Recruiting NCT05621278 - Children to Adults Mental and Psychosomatic Health Study (CAMPS)
Completed NCT05498415 - Feasibility, Acceptability, and Efficacy of the Sleep Move Stand Study N/A
Completed NCT03208569 - Anticholinergic Burden - Treatment Optimization
Completed NCT03793777 - The Effect of Aronia Melanocarpa Extract on Cognitive Function N/A
Recruiting NCT05525299 - Reminiscence-Based Life Review on Copying With Existential Suffering Among Older Cancer Survivors N/A
Completed NCT03698123 - Performance Nutrition for Residents and Fellows N/A
Completed NCT04543500 - Self-regulation of Prefrontal Cortex During Emotional Cognitive Control N/A
Recruiting NCT05591885 - Nutrilite Memory Builder on the Improvement of Cognitive Function N/A
Active, not recruiting NCT05575752 - Acute Health Effects of High Temperature Exposure N/A
Completed NCT03716609 - Effects of Magnesium Supplementation on Hemodynamic Parameters and Cognitive Function N/A
Completed NCT02763514 - The Effects of DHA- and EPA-enriched Oils on Cognitive Function and Mood N/A
Completed NCT02675621 - Investigation of Acute Mood and Cognitive Performance Effects of Beverages Containing Phenolics in Healthy Adults N/A
Completed NCT02277002 - Commuter Air Pollution Intervention Study N/A